NEW YORK, May 26, 2021 /PRNewswire/ — MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, announced today the publication of the first pharmacogenetic data on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback